Current Size: 100%

New paper out on p16 as predictive biomarker in squamous cell carcinoma

Lukas Kenner and colleagues report patients suffering from oropharyngeal squamous cell carcinoma without detectable p16 may benefit from postoperative radiotherapy, whereas p16-positive patients do not benefit from additional treatment. The report is now online in the journal Laryngoscope.